Screener
Editas Medicine EDIT Q1 2025 earnings
Reported May 12, 2025 · After market close
Revenue$4.7MBeat by $4.0M
EPS-$0.43Beat by $0.08
Revenue estimate$706.1K
EPS estimate-$0.51
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$4.5M
EPS estimate-$0.21
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Editas Medicine report Q1 2025 earnings?
- Editas Medicine (EDIT) reported Q1 2025 earnings on May 12, 2025 after market close.
- What were Editas Medicine's Q1 2025 revenue and EPS?
- Editas Medicine reported revenue of $4.7M and eps of $-0.43 for Q1 2025.
- Did Editas Medicine beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $706.1K by $4.0M. EPS beat the consensus estimate of $-0.51 by $0.08.
- How did Editas Medicine's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 310.4% from $1.1M a year earlier and eps grew 43.4% from $-0.76.
- Where can I find Editas Medicine's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001650664-25-000071) and the 10-Q periodic report (0001650664-25-000073) directly on SEC EDGAR. The filing index links above go to sec.gov.
